Groowe Groowe / Newsroom / DRMAW
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

DRMAW News

Dermata Therapeutics, Inc. Warrant

Dermata Receives Notice of Grant of Patent for Next-Generation Acne Treatment by Australian Patent Office

accessnewswire.com
DRMA DRMAW

Dermata Therapeutics Announces Closing of up to $12.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

accessnewswire.com
DRMA DRMAW

Dermata Therapeutics Announces up to $12.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

accessnewswire.com
DRMA DRMAW

A New Realm of Skincare is Coming: Dermata Teases New OTC Brand Identity

accessnewswire.com
DRMA DRMAW

Dermata Announces Acceptance of Patent Application for Next-Generation Acne Treatment by Australian Patent Office

accessnewswire.com
DRMA DRMAW

Dermata Therapeutics Announces Presentation of Abstract at the European Academy of Dermatology and Venereology Congress 2025

accessnewswire.com
DRMA DRMAW

Dermata Therapeutics Announces Strategic Pivot to Over-the-Counter Skin Care Treatments

accessnewswire.com
DRMA DRMAW